CEBPB Antikörper (AA 180-260)
-
- Target Alle CEBPB Antikörper anzeigen
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
-
Bindungsspezifität
- AA 180-260
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CEBPB Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Verwendungszweck
- C/EBP β is a protein encoded by the CEBPB gene which is approximately 36,1 kDa. C/EBP β is localised to the nucleus and cytoplasm. It is involved in IL-17 family signalling pathways, cellular senescence, human embryonic stem cell pluripotency and the IL-2 pathway. It functions as a homodimer but can also form heterodimers with enhancer-binding proteins alpha, delta, and gamma. Activity of this protein is important in the regulation of genes involved in immune and inflammatory responses, among other processes. C/EBP β is expressed at low levels in the lung, kidney and spleen. Mutations in the CEBPB gene may result in myxoid liposarcoma and leukaemia. STJ91918 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. This polyclonal antibody detects endogenous levels of C/EBP β protein.
- Spezifität
- C/EBP β Polyclonal Antibody detects endogenous levels of C/EBP β protein.
- Produktmerkmale
- Rabbit polyclonal to C/EBP β.
- Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Immunogen
- Synthesized peptide derived from human C/EBP beta around the non-phosphorylation site of T235.
- Isotyp
- IgG
- Top Product
- Discover our top product CEBPB Primärantikörper
-
-
- Applikationshinweise
-
WB 1:500-1:2000
IHC 1:100-1:300
ELISA 1:10000 - Kommentare
-
Expressed at low levels in the lung, kidney and spleen.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C, and avoid repeat freeze-thaw cycles.
-
- Target
- CEBPB (CCAAT/enhancer Binding Protein (C/EBP), beta (CEBPB))
- Andere Bezeichnung
- C/EBP beta (CEBPB Produkte)
- Synonyme
- C/EBPbeta antikoerper, c/ebp-beta antikoerper, crp2 antikoerper, il6dbp antikoerper, lap antikoerper, nf-il6 antikoerper, tcf5 antikoerper, xC/EBPbeta antikoerper, cebpbb antikoerper, cb380 antikoerper, c/ebpb antikoerper, fe11e05 antikoerper, wu:fe11e05 antikoerper, CEBPB antikoerper, LOC100136165 antikoerper, C/EBP-beta antikoerper, CRP2 antikoerper, IL6DBP antikoerper, LAP antikoerper, NF-IL6 antikoerper, TCF5 antikoerper, IL-6DBP antikoerper, LIP antikoerper, NF-M antikoerper, Nfil6 antikoerper, Il6dbp antikoerper, CCAAT/enhancer binding protein beta antikoerper, CCAAT/enhancer binding protein beta L homeolog antikoerper, CCAAT/enhancer binding protein (C/EBP), beta antikoerper, CCAAT/enhancer-binding protein beta antikoerper, cebpb antikoerper, cebpb.L antikoerper, CEBPB antikoerper, LOC100136165 antikoerper, Cebpb antikoerper
- Molekulargewicht
- 36 kDa
- Gen-ID
- 1051
- UniProt
- P17676
- Pathways
- Interferon-gamma Pathway, Autophagie, Brown Fat Cell Differentiation
-